HCPLive
JUNE 24, 2024
Teva Pharmaceuticals’ launch of an authorized generic of liraglutide injection 1.8 mg (Victoza) for type 2 diabetes makes it the first-ever generic GLP-1.
DAIC
JUNE 24, 2024
milla1cf Mon, 06/24/2024 - 20:21 June 24, 2024 — Endotronix, Inc. , a privately held company dedicated to advancing the treatment of heart failure ( HF ) at the intersection of digital health and medtech, today announced Premarket Approval (PMA) from the U.S Food and Drug Administration ( FDA ) of the company's Cordella Pulmonary Artery (PA) Sensor System for the treatment of New York Heart Failure (NYHA) class III heart failure patients.
HCPLive
JUNE 24, 2024
This analysis among Japanese patients highlights the potential of apremilast for psoriasis patients not responding to topical therapy who may have limited systemic treatment options.
DAIC
JUNE 24, 2024
June 24, 2024 — Well-known Chicago and worldwide philanthropist Ann Lurie, namesake of the Ann and Robert H Lurie Children’s Hospital of Chicago, passed away on June 24 after succumbing to glioblastoma, an aggressive form of brain cancer. She was 79. Lurie’s philanthropic efforts were numerous and impactful, and provided vital support to the critical needs of multiple agencies around the world, including initiatives addressing hunger, healthcare deficiencies, animal welfare, arts enrichment and
Med Page Today
JUNE 24, 2024
(MedPage Today) -- Note that some links may require registration or subscription. Princess Anne, the 73-year-old sister of King Charles III, sustained minor injuries and a concussion while on a walk; the cause is unclear, but her medical team.
DAIC
JUNE 24, 2024
Aakriti Gupta, MD. Photo by Cedars-Sinai milla1cf Mon, 06/24/2024 - 20:17 June 24, 2024 — Aakriti Gupta, MD , and Michelle Kittleson, MD, PhD , cardiologists in the Smidt Heart Institute at Cedars-Sinai , have been selected to join the senior editorial team of the Journal of the American College of Cardiology (JACC), effective July 1. Gupta, an interventional and structural cardiologist, is one of the journal’s new executive associate editors.
Med Page Today
JUNE 24, 2024
(MedPage Today) -- Metabolic surgery became the first therapy associated with a reduction in incident cardiovascular disease and death among patients with obesity and obstructive sleep apnea (OSA), based on a retrospective cohort study. Such patients.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
American College of Cardiology
JUNE 24, 2024
The first issue of JACC under new Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC, published today, ushering in a new era of one of the world's leading scholarly journals.
HCPLive
JUNE 24, 2024
A meta-analysis shows hand eczema has a moderate-to-severe impact on quality of life and anxiety.
American College of Cardiology
JUNE 24, 2024
Semaglutide reduces body weight to a greater extent in women with obesity-related heart failure with preserved ejection fraction (HFpEF) than in men, and improved Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS) to the same extent in both women and men, according to results from a prespecified secondary analysis of pooled data from the STEP-HFpEF program presented at the American Diabetes Association’s 2024 Scientific Sessions and simultaneously published in JACC.
HCPLive
JUNE 24, 2024
The announcement follows the release of the RhodoLED XL red light-emitting lamp, to be used in combination with aminolevulinic acid hydrochloride topical gel, 10% for actinic keratoses
American College of Cardiology
JUNE 24, 2024
The following are key points to remember from a state-of-the-art review addressing the global burden of cardiovascular disease (CVD) in women.
HCPLive
JUNE 24, 2024
Anastasia Albanese-O'Neill, PhD, APRN, joins Diabetes Dialogue to discuss newly released consensus guidance on monitoring of early-stage type 1 diabetes spearheaded by Breakthrough T1D.
Science Daily - Stroke
JUNE 24, 2024
Research illustrates that American Heart Association and American Stroke Association guidelines are effective at speeding up hospitals' response times for stroke treatment and can be mastered even by members of 'ad hoc' medical teams that assemble rapidly on the fly.
HCPLive
JUNE 24, 2024
Findings highlight the potential utility of low-dose SGLT2 inhibitors for optimizing diabetes control and managing renal complications in pediatric patients with type 1 diabetes.
Frontiers in Cardiovascular Medicine
JUNE 24, 2024
Dyslipidaemia is a complex disorder characterised by abnormal lipid levels in the blood, including cholesterol and triglycerides, and plays an important role in the development of atherosclerotic cardiovascular disease. Most risk factors for cardiovascular disease are modifiable, and dyslipidaemia is a key factor among them. It can result from a combination of genetic and environmental factors.
HCPLive
JUNE 24, 2024
Treatment with romosozumab or denosumab demonstrated comparable results among patients with either primary osteoporosis or those with rheumatoid arthritis complicated with osteoporosis over a 24-month period.
Alliance of Cardiovascular Professionals
JUNE 24, 2024
RCES-Scope-of-Practice-ACVP-2017 Available for download! The Electrophysiology Laboratory (EPL) is one of the most unique medical environments in existence today. The goal of the electrophysiology lab is to perform diagnostic studies to obtain sufficient electrocardiographic and radiologic data regarding bradyarrhythmias, or tachyarrythmias, and then to perform interventional procedures while maintaining maximal patient safety and comfort.
HCPLive
JUNE 24, 2024
CD40L blockade with dazodalibep benefited disease activity scores, including tender and swollen joints, in patients with moderate-to-severe active RA.
Cardiometabolic Health Congress
JUNE 24, 2024
As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S. Boca Raton, FL, June 24, 2024 (GLOBE NEWSWIRE) — The ADA 2024 Scientific Sessions center on the latest cutting-edge advances in diabetes research, prevention, and care.
HCPLive
JUNE 24, 2024
Patients who achieved early remission with upadacitinib or adalimumab following an inadequate response to methotrexate had less pain/fatigue and better physical quality of life.
The American Journal of Cardiology
JUNE 24, 2024
Publication date: Available online 24 June 2024 Source: The American Journal of Cardiology Author(s): Carlo Mannina, Lakshay Chopra, Joseph Maenza, Francesca R Prandi, Edgar Argulian, Michael Hadley, Jonathan Halperin, Samin K Sharma, Annapoorna Kini, Stamatios Lerakis
HCPLive
JUNE 24, 2024
Study results highlight the impact of continuous glucose monitoring on glucose control and HbA1c improvements in patients with type 2 diabetes, regardless of treatment regimen.
Frontiers in Cardiovascular Medicine
JUNE 24, 2024
BackgroundCannabis is one of the most widely used psychoactive substances. Its components act through several pathways, producing a myriad of side effects, of which cardiovascular events are the most life-threatening. However, only a limited number of studies address cannabis's perioperative impact on patients during noncardiac surgery.MethodsStudies were identified by searching the PubMed, Medline, EMBASE, and Google Scholar databases using relevant keyword combinations pertinent to the topic.R
HCPLive
JUNE 24, 2024
The CATALYST trial sheds light on the true prevalence of hypercortisolism among difficult-to-control type 2 diabetes, with data at ADA 2024 shedding light on adrenal abnormalities and presence among subgroups.
American College of Cardiology
JUNE 24, 2024
The goal of the SURMOUNT-OSA trial was to determine the effect of tirzepatide, both alone and in the setting of positive airway pressure (PAP) therapy, on obstructive sleep apnea (OSA) burden in patients with obesity.
HCPLive
JUNE 24, 2024
Vutrisiran achieved statistically significant reductions in primary and all secondary endpoints for patients with ATTR-CM in the HELIOS-B trial.
American College of Cardiology
JUNE 24, 2024
Greater adverse events were associated with both low and high postprocedural aortic valve mean gradient extremes following transcatheter aortic valve implantation (TAVI) for degenerated surgical aortic valve replacement (SAVR) bioprostheses, indicating a complex and nonlinear relationship between gradients and clinical outcomes, according to a recent study published in Circulation: Cardiovascular Interventions.
HCPLive
JUNE 24, 2024
Dubinett and Spira rejoin Lungcast for an update on their team's research into lung cancer interception.
American College of Cardiology
JUNE 24, 2024
Artificial intelligence (AI) has tremendous potential to transform cardiovascular care in several key areas, from discovery to practice, according to a JACC State-of-the-Art Review published June 24.
HCPLive
JUNE 24, 2024
At 8 months follow-up, 86.0% of patients with rheumatoid arthritis were in remission and 94.2% exhibited low disease activity.
HeartRhythm
JUNE 24, 2024
Vagal atrial fibrillation (AF) occurs in relatively young people without any organic heart disease, and its onset is caused by changes in autonomic nervous system tone, mainly parasympathetic, such as after eating or drinking alcohol. Clinical results demonstrate that pulmonary vein isolation (PVI) remains the cornerstone of AF ablation in these patients, but additional ablation of the ganglionated plexi (GP) has been proposed as a complementary strategy.
HCPLive
JUNE 24, 2024
Data on outcomes stratified according to baseline use of SGLT2 inhibitors from the FLOW trial were presented at ADA 2024.
American College of Cardiology
JUNE 24, 2024
Are nicotine-containing electronic cigarettes (ECs) effective compared to varenicline for smoking cessation?
HCPLive
JUNE 24, 2024
A national survey provides insight into the prevalence of arthritis based on race in the US from 2011 – 2018.
BMH Medical Journal
JUNE 24, 2024
Oxytocin, the most commonly used drug to induce labor, may cause adverse effects due to uterine hyperstimulation. The aim of this study is to compare the maternal and fetal outcomes of discontinued or continued oxytocin during the active phase of labor induction. This study was conducted on 70 pregnant women referred to Baath Mission Hospital in Sanandaj, Iran.
Journal of Cardiovascular Pharmacology
JUNE 24, 2024
Sodium/glucose cotransporter 2 (SGLT2) inhibitors are a novel class of anti-diabetic medications which have proved capable of providing breakthrough cardiovascular benefits in a variety of clinical scenarios, including patients with heart failure or obesity, irrespective of diabetic status. Several SGLT2 inhibitors are available, but the most prominent ones are canagliflozin, dapagliflozin, and empagliflozin.
Expert insights. Personalized for you.
142 
Let's personalize your content